Skip to content

Extra Volume reflector 6888985

by Maquet Critical Care AB

Extra Volume reflector 6888985 is an anaesthesia workstation (FDA Class II; FDA product code BSZ, Gas-Machine, Anesthesia) made by Maquet Critical Care AB, cleared under FDA 510(k) K191027 on 18 Mar 2020 and listed in FDA GUDID since 26 May 2020 (UDI-DI 07325710010860), active as of 23 Oct 2026. 11 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

8 ongoing

This device is named in the recall

Documents

510(k) K191027

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number07325710010860 UDI-DI Date26 May 2020ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK191027 Date18 Mar 2020DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K191027 decided 18 Mar 2020 Active
  • FDA GUDID UDI-DI 07325710010860 listed 26 May 2020 Listed

Recalls

11 recalls · 8 ongoing · FDA

    • Ongoing Z-2860-2026 FDA Class II initiated 24 Jun 2026

    Events observed where anesthetic agent was not delivered when the vaporizer was activated. Failure to deliver the anesthetic agent may result in the patient receiving insufficient anesthesia and may lead to intraoperative awareness.

  • 2 recalls, same reason

    • Ongoing Z-1074-2025 FDA Class I initiated 15 Jan 2025
    • Ongoing Z-1877-2024 FDA Class I initiated 1 May 2024

    Sevoflurane used with the vaporizer may degrade to hydrogen fluoride, which could present a risk to patients or health care providers through inhalation and/or skin exposure. Potential harms include irritation of respiratory tract, which in worst case may lead to lung edema and/or severe hypocalcemia, blistering, superficial ulceration, and/or hypomagnesemia.

  • 3 recalls, same reason

    • Ongoing Z-0961-2023 FDA Class I initiated 22 Dec 2022
    • Ongoing Z-0959-2023 FDA Class I initiated 22 Dec 2022
    • Ongoing Z-0960-2023 FDA Class I initiated 22 Dec 2022

    Due to a software bug, under certain conditions, pressure cannot be built up resulting in no ventilation. If gas delivery is stopped, a sustained decrease in delivered O2 concentration may lead to hypoventilation and hypoxia.

    • Ongoing Z-0422-2023 FDA Class II initiated 7 Nov 2022

    The power backup battery, under certain conditions, may exhibit reduced battery run-time while in use, and there is a potential that the battery may fail to provide the expected run time in the event of a mains power failure. This could require the clinician to use manual emergency ventilation of another ventilator is not available and the backup battery is exhausted.

    • Ongoing Z-0468-2022 FDA Class I initiated 9 Dec 2021

    A potential chemical degradation of Sevoflurane by Lewis acids (metal oxides and metal halides) has been discovered that may result in inhalation and/or skin exposure of hydrogen fluoride.

  • 2 recalls, same reason

    • Terminated Z-1279-2022 FDA Class I initiated 2 May 2022
    • Terminated Z-1278-2022 FDA Class I initiated 2 May 2022

    Potential for crack to form on the on/off switch of the suction unit, which may result in an unreasonable risk of harm to the patient. In the worst case, the switch can break, preventing the suction unit from being activated.

    • Terminated Z-1181-2021 FDA Class II initiated 29 Jan 2021

    Maquet Critical Care AB received complaints where the FiCO2 value was not zero or as close to zero as expected and/or experienced System Check Out failures when docking the absorber to the Flow i Anesthesia machine.

Timeline

13 dated events

  1. Recall initiated FDA recalls Z-0468-2022
  2. Recall initiated FDA recalls Z-1279-2022
  3. Recall initiated FDA recalls Z-1278-2022
  4. Recall initiated FDA recalls Z-0422-2023
  5. Recall initiated FDA recalls Z-0961-2023
  6. Recall initiated FDA recalls Z-0959-2023
  7. Recall initiated FDA recalls Z-0960-2023
  8. Recall initiated FDA recalls Z-1877-2024
  9. Recall initiated FDA recalls Z-1074-2025
  10. Recall initiated FDA recalls Z-2860-2026

3 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Extra Volume reflector
Generic name
Anaesthesia workstation, general-purpose
Model / reference
6888985
Primary DI / UDI-DI
07325710010860
510(k) Number
FDA product code
BSZ
GMDN term
Anaesthesia workstation, general-purpose
Device class
Class II
Regulation number
868.5160
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code BSZ (Gas-Machine, Anesthesia).

Other devices from Maquet Critical Care AB

See all devices from Maquet Critical Care AB →

Properties

  • Prescription use
  • Lot / batch number
  • Manufacturing date
Other properties (12, all answered No)